Literature DB >> 2526215

Activation of ATP-sensitive outward K+ current by nicorandil (2-nicotinamidoethyl nitrate) in isolated ventricular myocytes.

M Hiraoka1, Z Fan.   

Abstract

The vasodilatory agent, nicorandil (2-nicotinamidoethyl nitrate) activates an outward K+ current in cardiac and vascular smooth muscle. This current was studied with the patch clamp technique using isolated guinea pig and rabbit ventricular myocytes. Nicorandil (10(-5) and 10(-4) M) shortened the action potential duration without any significant change in the resting membrane potential. Under voltage clamp, nicorandil increased the time-independent outward current at potentials positive to -80 mV, and decreased the inward current at potentials negative to -90 mV. The drug did not affect Ca++ current activated upon depolarization from the holding potential of -30 mV, or did it influence delayed outward K+ current on repolarization. In rabbit myocytes, nicorandil did not increase the Ca++-sensitive and -insensitive transient outward K+ currents. When the ATP concentration of the pipette solution was reduced from 5 to 2 to 3 mM, nicorandil produced a large increase in outward current, which decreased slightly with time. The increased outward current was antagonized by raising the intracellular ATP concentration. Nicorandil increased the probability of opening of the ATP-sensitive single channel current without affecting its unitary amplitude. These results indicate that nicorandil activates the ATP-sensitive K+ current, which is responsible for shortening of the action potential duration.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2526215

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  30 in total

1.  Activation of ATP-sensitive K channels by a K channel opener (SR 44866) and the effect upon electrical and mechanical activity of frog skeletal muscle.

Authors:  M P Sauviat; E Ecault; J F Faivre; I Findlay
Journal:  Pflugers Arch       Date:  1991-04       Impact factor: 3.657

Review 2.  Electrophysiologic effects of potassium channel openers.

Authors:  W Haverkamp; M Borggrefe; G Breithardt
Journal:  Cardiovasc Drugs Ther       Date:  1995-03       Impact factor: 3.727

Review 3.  Pharmacology of the potassium channel openers.

Authors:  G Edwards; A H Weston
Journal:  Cardiovasc Drugs Ther       Date:  1995-03       Impact factor: 3.727

4.  Pinacidil activates the ATP-sensitive K+ channel in inside-out and cell-attached patch membranes of guinea-pig ventricular myocytes.

Authors:  Z Fan; K Nakayama; M Hiraoka
Journal:  Pflugers Arch       Date:  1990-01       Impact factor: 3.657

Review 5.  Ischemic myocardial cell protection conferred by the opening of ATP-sensitive potassium channels.

Authors:  I Cavero; Y Djellas; J M Guillon
Journal:  Cardiovasc Drugs Ther       Date:  1995-03       Impact factor: 3.727

Review 6.  Impact of hypoglycemic agents on myocardial ischemic preconditioning.

Authors:  Rosa Maria Rahmi Garcia; Paulo Cury Rezende; Whady Hueb
Journal:  World J Diabetes       Date:  2014-06-15

7.  Cibenzoline inhibits diazoxide- and 2,4-dinitrophenol-activated ATP-sensitive K+ channels in guinea-pig ventricular cells.

Authors:  T Sato; B Wu; S Nakamura; T Kiyosue; M Arita
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

8.  The protective effects of cromakalim and pinacidil on reperfusion function and infarct size in isolated perfused rat hearts and anesthetized dogs.

Authors:  G J Grover; S Dzwonczyk; C S Parham; P G Sleph
Journal:  Cardiovasc Drugs Ther       Date:  1990-04       Impact factor: 3.727

Review 9.  Nicorandil. A review of its pharmacology and therapeutic efficacy in angina pectoris.

Authors:  J Frampton; M M Buckley; A Fitton
Journal:  Drugs       Date:  1992-10       Impact factor: 9.546

10.  Contribution of potassium accumulation in narrow extracellular spaces to the genesis of nicorandil-induced large inward tail current in guinea-pig ventricular cells.

Authors:  K Yasui; T Anno; K Kamiya; M R Boyett; I Kodama; J Toyama
Journal:  Pflugers Arch       Date:  1993-01       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.